Capital Fund Management S.A. Dexcom Inc Put Options Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $8.2 Million - $10.4 Million	-74,300 Reduced 44.44%	92,900 $10.5 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $31.3 Million - $38.4 Million	-273,900 Reduced 62.09%	167,200 $23.2 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $19.9 Million - $32.8 Million	264,000 Added 149.07%	441,100 $54.7 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $4.77 Million - $7.64 Million	55,400 Added 45.52%	177,100 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $13.7 Million - $15.9 Million	121,700 New	121,700 $15.6 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $4.55 Million - $6.58 Million	-53,600 Reduced 76.24%	16,700 $1.89 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $274,860 - $339,048	-3,600 Reduced 4.87%	70,300 $5.66 Billion
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $5.02 Million - $9.82 Million	73,900 New	73,900 $5.51 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $826,800 - $1.11 Million	-10,600 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $1.01 Million - $1.2 Million	10,600 New	10,600 $1.09 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $195,415 - $240,899	-5,500 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$27.84 - $38.92 $83,520 - $116,760	3,000 Added 120.0%	5,500 $824,000
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $529,004 - $732,452	-19,600 Reduced 88.69%	2,500 $300,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $403,955 - $635,256	17,300 Added 360.42%	22,100 $3.16 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $84,192 - $121,056	4,800 New	4,800 $456,000

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account